Dr. Driesmann, a leader in the diagnostics industry, will guide Stemina’s commercialization strategy. Read the full press release.
Read moreMetabolic Profiling of the Children’s Autism Metabolome Project (CAMP) NeuroPointDX is conducting a research study called Children’s Autism
Read moreTogether, Ovid and NeuroPointDX will use metabolomics data to better understand the rare neuro-genetic disorder known as Angelman
Read moreStemina’s CEO, Beth Donley, will deliver the welcome remarks at the 64th Annual Greater Madison Chamber of Commerce
Read moreThe International Meeting for Autism Research (IMFAR) will be held in Baltimore, Maryland May 11-14. Visit the Saturday
Read moreA University of Wisconsin—Madison spinoff is screening blood samples in an effort to develop a biologically based method
Read moreStemina’s CEO, Beth Donley, is named Executive of the Year by Madison’s InBusiness Magazine. Read the Article
Read moreWith a new $2.7 million federal grant in hand, Stemina Biomarker Discovery has launched a 1,500-patient study of
Read moreStemina Biomarker Discovery Inc. today announced the launch of the largest clinical study of the metabolism of children
Read moreThe International Meeting for Autism Research (IMFAR) is a scientific meeting to exchange and disseminate new scientific progress
Read more